Loss of CpG methylation is strongly correlated with loss of histone H3 lysine 9 methylation at DMR-LIT1 in patients with Beckwith-Wiedemann syndrome

被引:40
|
作者
Higashimoto, K
Urano, T
Sugiura, K
Yatsuki, H
Joh, K
Zhao, W
Iwakawa, M
Ohashi, H
Oshimura, M
Niikawa, N
Mukai, T
Soejima, H
机构
[1] Saga Med Sch, Dept Biomol Sci, Div Mol Biol & Genet, Saga 8498501, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Dermatol, Div Connect Tissue Dis & Autoimmun, Nagoya, Aichi, Japan
[4] Natl Inst Radiol Sci, Frontier Res Ctr, Chiba 260, Japan
[5] Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan
[6] Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Yonago, Tottori, Japan
[7] Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan
[8] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Japan
关键词
D O I
10.1086/378595
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To clarify the chromatin-based imprinting mechanism of the p57(KIP2)/LIT1 subdomain at chromosome 11p15.5 and the mouse ortholog at chromosome 7F5, we investigated the histone-modification status at a differentially CpG methylated region of Lit1/LIT1 (DMR-Lit1/LIT1), which is an imprinting control region for the subdomain and is demethylated in half of patients with Beckwith-Wiedemann syndrome (BWS). Chromatin-immunoprecipitation assays revealed that, in both species, DMR-Lit1/LIT1 with the CpG-methylated, maternally derived inactive allele showed histone H3 Lys9 methylation, whereas the CpG-unmethylated, paternally active allele was acetylated on histone H3/H4 and methylated on H3 Lys4. We have also investigated the relationship between CpG methylation and histone H3 Lys9 methylation at DMR-LIT1 in patients with BWS. In a normal individual and in patients with BWS with normal DMR-LIT1 methylation, histone H3 Lys9 methylation was detected on the maternal allele; however, it disappeared completely in the patients with the DMR-LIT1 imprinting defect. These findings suggest that the histone-modification status at DMR-Lit1/LIT1 plays an important role in imprinting control within the subdomain and that loss of histone H3 Lys9 methylation, together with CpG demethylation on the maternal allele, may lead to the BWS phenotype.
引用
收藏
页码:948 / 956
页数:9
相关论文
共 50 条
  • [1] Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer
    Hidenobu Soejima
    Tetsuji Nakagawachi
    Wei Zhao
    Ken Higashimoto
    Takeshi Urano
    Shiroh Matsukura
    Yoshihiko Kitajima
    Makoto Takeuchi
    Masahiro Nakayama
    Mitsuo Oshimura
    Kohji Miyazaki
    Keiichiro Joh
    Tsunehiro Mukai
    Oncogene, 2004, 23 : 4380 - 4388
  • [2] Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer
    Soejima, H
    Nakagawachi, T
    Zhao, W
    Higashimoto, K
    Urano, T
    Matsukura, S
    Kitajima, Y
    Takeuchi, M
    Nakayama, M
    Oshimura, M
    Miyazaki, K
    Joh, K
    Mukai, T
    ONCOGENE, 2004, 23 (25) : 4380 - 4388
  • [3] Deletion in Lit1 CpG Island Associated with Aberrant Lack of Methylation and Beckwith-Wiedemann Syndrome
    Bosler, D. S.
    Martin, J.
    Simpson, L.
    Highsmith, W. E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 573 - 573
  • [4] H19DMR methylation analysis in patients with Beckwith-Wiedemann syndrome and isolated hemihyperplasia
    Gomes, MVD
    dos Santos, SA
    Ramos, ES
    GENETICS AND MOLECULAR BIOLOGY, 2005, 28 (02) : 210 - 213
  • [5] Loss of methylation at KvDMR1 is a frequent epigenetic change in Beckwith-Wiedemann syndrome.
    Day, CD
    Diaz-Meyer, N
    Junien, C
    Der Kaloustian, VM
    Graham, GE
    Bridge, PJ
    Algar, EM
    Maher, ER
    Shows, TB
    Higgins, MJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 343 - 343
  • [6] ABNORMAL METHYLATION OF LIT1 IN FEMALE MONOZYGOTIC TWINS DISCORDANT FOR BECKWITH-WIEDEMANN SYNDROME
    Zadeh, N.
    Zadeh, T. M.
    Manning, M. A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (01) : 183 - 184
  • [7] THE PHENOTYPIC SPECTRUM OF BECKWITH-WIEDEMANN SYNDROME DUE TO LOSS OF METHYLATION AT IMPRINTING CENTER 2
    Yu, A.
    Duffy, K.
    Hathaway, E.
    Kelly, J.
    Richards-Yutz, J.
    Deardorff, M. A.
    Ganguly, A.
    Kalish, J. M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2019, 179 (04) : 703 - 704
  • [8] The Addition of H19 'Loss of Methylation Testing' for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield
    Lennerz, J. K.
    Grange, D. K.
    DeBaun, M. R.
    Zehnbauer, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 620 - 620
  • [9] Addition of H19 'Loss of Methylation Testing' for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield
    Lennerz, Jochen K.
    Timmerman, Robert J.
    Grange, Dorothy K.
    DeBaun, Michael R.
    Feinberg, Andrew P.
    Zehnbauer, Barbara A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (05): : 576 - 588
  • [10] Revisiting Wilms tumour surveillance in Beckwith-Wiedemann syndrome with IC2 methylation loss
    Brioude, Frederic
    Hennekam, Raoul
    Bliek, Jet
    Coze, Carole
    Eggermann, Thomas
    Ferrero, Giovanni B.
    Kratz, Christian
    Le Bouc, Yves
    Maas, Saskia M.
    Mackay, Deborah J. G.
    Maher, Eamonn R.
    Mussa, Alessandro
    Netchine, Irene
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 (04) : 471 - 472